SCHEMBL7697005

SCHEMBL7697005

CC(C)(CCCC=O)CCCC(C)(C)O[Si](C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30040429 0.93 HIF1A (0.36) TSHRHIF1A
SCHEMBL7700413 0.80
SCHEMBL7700798 0.78 CYP3A4 (0.33)
SCHEMBL7700803 0.78 CYP3A4 (0.33)
SCHEMBL27785813 0.74 TSHR (0.46) TSHRHIF1A
SCHEMBL7698924 0.73 FAAH (0.31)
SCHEMBL7704389 0.73
SCHEMBL7698919 0.73 FAAH (0.31)
SCHEMBL7704790 0.71 ALDH1A1 (0.38) TSHRHIF1A
SCHEMBL1783206 0.70 TSHR (0.59) TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056716-B1 CYCLOHEXANEDIOLE DERIVATIVES BASILEA PHARMACEUTICA AG (CH) 2002-12-11 EP disclosed
US-6184422-B1 TREATMENT AND PREVENTION OF HYPERPROLIFERATIVE SKIN DISEASES; REVERSING CONDITIONS ASSOCIATED WITH PHOTODAMAGE; ANTITUMOR, -CARCINOGENIC AGENTS; PSORIASIS; DISORDERS OF NEOPLASTIC DISEASES; KERATINIZATION/KERATOSIS; ACNE; SEBORRHEA HOFFMAN-LA ROCHE INC. 2001-02-06 US disclosed
EP-1056716-A1 CYCLOHEXANEDIOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-12-06 EP disclosed
WO-1999043646-A1 CYCLOHEXANEDIOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-09-02 WO disclosed